LBLucas R. A. Beffa

Lucas R. A. Beffa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lucas R. A. Beffa has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A modern comparison of suture repair versus mesh repair for incisional hernia: a study protocol for a randomized controlled trial

    by Sara M. Maskal, Benjamin T. Miller, Ryan C. Ellis, Lucas R. A. Beffa, Ajita S. Prabhu, Michael J. Rosen, David M. Krpata, Li-Ching Huang, Clayton C. Petro

    The utilization of mesh is considered the standard of care for incisional hernia repairs to reduce recurrence. However, mesh complications—including infection and enterocutaneous fistulae—can impact patients’ quality of life and culminate in reoperation. Meanwhile, techniques for fascial closure and our understanding of abdominal wall tension physiology have improved since the original studies comparing suture and mesh-based ventral hernia repairs were published, but there have been no contemporary trials comparing these approaches since the evolution of fascial closure techniques. This is a registry-based, multicenter, patient-blinded randomized controlled trial designed to investigate whether a suture-only technique utilizing a posterior rectus sheath release, small bite technique, and 4:1 closure is non-inferior to a retrorectus mesh-based repair for clean, incisional hernias that are 2–6 cm in width. The primary study endpoint is abdominal wall-specific quality of life (HerQLes) at one year postoperatively. Our primary hypothesis is that suture-based incisional hernia repair will be non-inferior to mesh-based repairs with respect to HerQLes summary score at one year postoperatively. Secondary outcomes of interest include hernia recurrence at 1, 2, and 5 years postoperatively, pain as measured by the PROMIS-3a Pain Intensity survey, cost-effectiveness ratios, 30-day readmissions, wound complications, and reoperations. Additional outcomes include hernia recurrence, patient-reported quality of life, wound complications, and hernia-related reoperation at 30 days, 1 year, 2 years, and 5 years. The risks of mesh-related complications, coupled with the lack of contemporary data, warrant new investigation into the necessity of mesh placement for all incisional hernias. Clinicaltrials.gov NCT05599750. Registered on October 26, 2022.


  • Opioid prescribing practices and patient-requested refill patterns following laparoscopic inguinal hernia repair

    by C. K. Gentle, J. D. Thomas, K. C. Montelione, C. Tu, A. S. Prabhu, D. M. Krpata, L. R. Beffa, S. Rosenblatt, M. J. Rosen, E. Lo Menzo, et al.

    Purpose Excessive post-operative opioid prescribing has led to efforts to match prescriptions with patient need after surgery. We investigated opioid prescribing practices, rate of patient-requested opioid refills, and associated factors after laparoscopic inguinal hernia repair (LIHR). Methods LIHRs at a single institution from 3/2019 to 3/2021 were queried from the Abdominal Core Health Quality Collaborative for demographics, perioperative details, and patient-reported opioid usage. Opioid prescriptions at discharge and opioid refills were extracted from the medical record. Univariate and multivariable regression were used to identify factors associated with opioid refills within 30-days of surgery. Results Four hundred and ninety LIHR patients were analyzed. The median number of opioid tablets prescribed was 12 [interquartile range (IQR) 10–15], and 4% requested a refill. On univariate analysis, patients who requested refills were younger [55 years (IQR 37–61) vs. 62 years (IQR 36.8–61), p = 0.012], more likely to have undergone transabdominal preperitoneal repair (75% vs. 26.4%, p < 0.001), have a scrotal component (30% vs. 11%, p = 0.022), and have permanent tacks used (80% vs. 49.4%, p = 0.014). There was a 12% increase in the odds of opioid refill for every 1 tablet of oxycodone prescribed at discharge (95% CI for OR 1.04–1.21, p = 0.003) after controlling for age and surgery type. Patient-reported opioid use was available for 289 (59%) patients. Post-operatively, 67% of patients used ≤ 4 opioid tablets, and 87% used no more than 10 opioid tablets. Conclusion Most patients use fewer opioid tablets than prescribed. Requests for opioid refills are rare following LIHR (4%) and associated with higher opioid prescribing.


  • Abdominal Wall Hernias

    by Jacob A. Quick, Lucas R. A. Beffa, Stephen L. Barnes

  • Open Access

    Comparing Sugarbaker versus keyhole mesh technique for open retromuscular parastomal hernia repair: study protocol for a registry-based randomized controlled trial

    by Benjamin T. Miller, Jonah D. Thomas, Chao Tu, Adele Costanzo, Lucas R. A. Beffa, David M. Krpata, Ajita S. Prabhu, Michael J. Rosen, Clayton C. Petro

    Background: Parastomal hernia, common after stoma creation, negatively impacts patient quality of life. For patients with a permanent stoma, durable parastomal hernia repair remains a challenge, with few high-quality studies for guidance. An alternative to open retromuscular parastomal hernia repair with retromuscular “keyhole” mesh is the recent Sugarbaker modification. We aim to compare these two techniques in a head-to-head prospective study. Methods: This is a registry-based randomized controlled trial designed to investigate whether the retromuscular Sugarbaker technique is superior to the retromuscular keyhole technique for parastomal hernia repair. The primary study endpoint is parastomal hernia recurrence at 2 years. Secondary endpoints include hospital length-of-stay, readmission, wound morbidity, mesh-related complications, re-operation, all 30-day morbidity, and patient-reported outcomes, including hernia-related quality of life, stoma-specific quality of life, pain, and decision regret. Discussion: Based on the post hoc analysis of a recent randomized controlled trial, we hypothesize that the retromuscular Sugarbaker technique will reduce parastomal hernia recurrence by 20% at 2 years compared to the retromuscular keyhole mesh technique. The results of this study may provide evidence-based guidance for surgeons repairing parastomal hernias. Trial registration: ClinicalTrials.gov NCT03972553. Registered on 3 June 2019